A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris

Dermatology

Volumn 216, Issue 1, 2007, Pages 64-67

  Matsushita, Takashi ^a   Hasegawa, Minoru ^a   Shirasaki, Fumiaki ^a   Fujimoto, Manabu ^a   Yamazaki, Hirohito ^a   Sato, Shinichi ^b   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Acute graft versus host disease; Psoralen UVA; Psoriasis vulgaris

Indexed keywords

COLECALCIFEROL; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PSORALEN; STEROID; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; PSORIASIS; PSORIASIS VULGARIS; PUVA; RASH; SKIN MANIFESTATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PSORIASIS; PUVA THERAPY; SKIN;

EID: 36348929954     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109361     Document Type: Article

References (18)

1. Billingham RE: The biology of graft-versus-host reactions. Harvey Lect 1966;62:21-78.
2. Aractingi S, Chosidow O: Cutaneous graft-versus-host disease. Arch Dermatol 1998;134:602-612.
3. Lebwohl M: Psoriasis. Lancet 2003;361:1197-1204.
4. Masszi T, Farkas A, Remenyi P, Lueff S, Batai A, Krivan G, Kemeny L, Dobozy A, Reti M: Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation. Dermatology 2006;212:88-89.
5. Kanamori H, Tanaka M, Kawaguchi H, Yamaji S, Fujimaki K, Tomita N, Fujisawa S, Ishigatsubo Y: Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol 2002;71:41-44.
6. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Saint Andre JP, Verret JL: Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol 1990;126:1523.
7. Snowden JA, Heaton DC: Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 1997;137:130-132.
8. Henseler T: The genetics of psoriasis. J Am Acad Dermatol 1997;37:S1-S11.
9. Henseler T, Christophers E: Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-456.
10. Nakagawa H, Akazaki S, Asahina A, Tokunaga K, Matsuki K, Kuwata S, Ishibashi Y, Juji T: Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis. Arch Dermatol Res 1991;283:281-284.
11. Mueller W, Herrmann B: Cyclosporine A for psoriasis. N Engl J Med 1979;301:555.
12. Nickoloff BJ, Wrone-Smith T: Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999;155:145-158.
13. Wiesmann A, Weller A, Lischka G, Klingebiel T, Kanz L, Einsele H: Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study. Bone Marrow Transplant 1999;23:151-155.
14. Aubin F, Mousson C: Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation 2004;77:S29-S31.
15. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL: CD4+CD25+ immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196:401-406.
16. Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR, McCormick TS, Cooper KD: Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005;174:164-173.
17. Bovenschen HJ, van Vlijmen-Willems IM, van de Kerkhof PC, van Erp PE: Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in psoriasis. Dermatology 2006;213:111-117.
18. Ashworth J, Kahan MC, Breathnach SM: PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function. Br J Dermatol 1989;120:329-339.